{"doi":"10.1093/milmed/usab489","title":"Prevention of Alcohol-related Incidents in the U.S. Air Force: Results From a Cluster Randomized Trial","abstract":"BACKGROUND: Alcohol misuse poses significant public health concerns in the U.S. Military. An Alcohol Misconduct Prevention Program (AMPP), which includes a brief alcohol intervention (BAI) session, plus random breathalyzer program, has been shown to reduce alcohol-related incidents (ARIs) among Airmen undergoing training. PURPOSE: The current study sought to examine whether a booster BAI administered at the end of Airmen's training reduced ARIs out to a 1-year follow-up. METHODS: Participants were 26,231 U.S. Air Force Technical Trainees recruited between March 2016 and July 2018. Participants were cluster randomized by cohort to two conditions: AMPP + BAI Booster or AMPP + Bystander Intervention. The primary analysis was a comparison of the interventions' efficacies in preventing Article 15 ARIs at a 1-year follow-up, conducted using a generalized estimating equations logistic regression model controlling for covariates. RESULTS: There was no significant difference by condition in Article 15 ARIs at the 1-year follow-up (P = .912). CONCLUSIONS: Findings suggest that a booster may not be necessary to produce maximum effects beyond the initial AMPP intervention. It is also possible that alcohol behaviors changed as a result of the intervention but were not captured by our outcome measures. Future research should consider alternative outcomes or participant-tracking measures to determine whether a different or more intensive BAI booster is effective. The majority of Article 15 ARIs were for underage drinking; therefore, developing an intervention focused on this problem behavior could lead to large reductions in training costs in the military.","journal":"Military Medicine","year":2021,"id":210125,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9687,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":453757,"name":"Robert C. Klesges","orcid":null,"position":1,"is_corresponding":false},{"id":513151,"name":"Indika Mallawaarachchi","orcid":"0000-0002-4137-5728","position":2,"is_corresponding":false},{"id":357015,"name":"Timothy L. McMurry","orcid":"0000-0001-5912-5092","position":3,"is_corresponding":false},{"id":513806,"name":"Kinsey Pebley","orcid":"0000-0002-7497-6247","position":4,"is_corresponding":false},{"id":702625,"name":"Meghan E. McDevitt‐Murphy","orcid":"0000-0002-3880-7083","position":5,"is_corresponding":false},{"id":671106,"name":"James G. Murphy","orcid":"0000-0001-9378-8754","position":6,"is_corresponding":false},{"id":443926,"name":"G. Wayne Talcott","orcid":"0000-0002-5954-4921","position":7,"is_corresponding":false},{"id":452612,"name":"Melissa A. Little","orcid":"0000-0002-0562-4010","position":0,"is_corresponding":true}],"reference_count":24,"raw_metadata":null,"created_at":"2026-07-18T23:52:08.869117Z","pmid":"34865112","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}